Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, February 12, 2015. The schedule for the press release and conference call is as follows:
• | Q4 & YE 2014 Press Release: | February 12, 2015 at 7:00 a.m. ET | ||||||||||
• | Q4 & YE 2014 Conference Call: | February 12, 2015 at 8:30 a.m. ET | ||||||||||
• | Domestic Dial-In Number: | 877-407-8037 | ||||||||||
• | International Dial-In Number: | 201-689-8037 | ||||||||||
• | Conference ID Number: | 13599385 | ||||||||||
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13599385.
The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Contacts:
Pamela M. Murphy
Vice
President, Investor Relations & Corporate Communications
302-498-6944
